Investigation of differentially expressed genes in ER plus PR- invasive breast cancer

被引：0
|
作者：
Althobiti, M. M. A. [1 ]
Albugami, R. R. A. [2 ]
Alnamnakani, M. M. A. [2 ]
Alharbi, S. A. A. [1 ]
Lashin, A. G. [3 ]
机构：
[1] Shaqra Univ, Riyadh, Saudi Arabia
[2] King Fahad Med City, Riyadh, Saudi Arabia
[3] Univ Nottingham, Nottingham, England
来源：
JOURNAL OF PATHOLOGY | 2024年 / 264卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P18
引用
收藏
页码：S11 / S12
页数：2
相关论文
共 50 条
  • [21] Integrated analysis of differentially expressed genes in breast cancer pathogenesis
    Chen, Daobao
    Yang, Hongjian
    ONCOLOGY LETTERS, 2015, 9 (06) : 2560 - 2566
  • [22] ANALYSES ON DIFFERENTIALLY EXPRESSED GENES ASSOCIATED WITH HUMAN BREAST CANCER
    孟旭莉
    丁小文
    徐笑红
    Chinese Journal of Cancer Research, 2006, (03) : 193 - 197
  • [23] Differentially expressed genes and estrogen receptor status in breast cancer
    Nagai, MA
    Ros, N
    Bessa, SA
    Neto, MM
    Miracca, EC
    Brentani, MM
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (05) : 1425 - 1430
  • [24] Differentially expressed coagulome genes (DECGs) are prognostic in breast cancer
    Tinholt, M.
    Tekpli, X.
    Kristensen, V.
    Sandset, P. M.
    Iversen, N.
    THROMBOSIS RESEARCH, 2022, 213 : S7 - S8
  • [25] Is Estrogen Receptor Positive (ER plus ) Progesterone Receptor Negative (PR-) Invasive Lobular Carcinoma a Distinct Clinicopathologic Subset?
    Gadde, Ramya
    Chitale, Dhananjay
    MODERN PATHOLOGY, 2017, 30 : 41A - 42A
  • [26] Clinical study of first-line endocrine therapy for type ER+/PR+ and ER+/PR- advanced breast cancer
    Zhang, Mengwei
    Yan, Min
    Lv, Huimin
    Niu, Limin
    Zeng, Huiai
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) : 238 - 243
  • [27] Lacrimal gland metastasis from invasive lobular carcinoma (ER+, PR-, Her-2+) as the first manifestation of disseminated breast cancer
    Laforga, Juan B.
    BREAST JOURNAL, 2020, 26 (04): : 762 - 763
  • [28] Estrogen Receptor Positive/Progesterone Receptor Negative/(ER plus /PR-) Breast Cancer (BC) Has a Poor Response to Endocrine Therapy (ET)
    Guo, Tao
    Shen, Tiansheng
    Britt, Jacob
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    LABORATORY INVESTIGATION, 2017, 97 : 44A - 44A
  • [29] Estrogen Receptor Positive/Progesterone Receptor Negative/(ER plus /PR-) Breast Cancer (BC) Has a Poor Response to Endocrine Therapy (ET)
    Guo, Tao
    Shen, Tiansheng
    Britt, Jacob
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    MODERN PATHOLOGY, 2017, 30 : 44A - 44A
  • [30] ERE-independent ERα target genes differentially expressed in human breast tumors
    Glidewell-Kenney, C
    Weiss, J
    Lee, EJ
    Pillai, S
    Ishikawa, T
    Ariazi, EA
    Jameson, JL
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 245 (1-2) : 53 - 59
12345